Screening At-risk Populations for Hepatic Fibrosis With Non-invasive Markers | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Screening At-risk Populations for Hepatic Fibrosis With Non-invasive Markers	Chemically-Induced Disorders, Digestive System Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, alcohol-induced disorders, alcohol-related disorders, alcoholic liver disease, cirrhosis of liver, fatty liver disease, liver disorder, metabolic dysfunction-associated steatotic liver disease, substance-related disorder	Recruiting	Not applicable	2022-09-01		NCT03308916

16 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Biomedical Research Foundation, Academy of Athens	4
Esbjerg University Hospital of South-West Jutland	2
Heidelberg University	49
Horizon 2020 - European Commission	13
Maja Thiele	1
Manatee APS	1
Nordic Bioscience A/S	4
Novo Nordisk A/S	181
Odense Municipality Alcohol Rehabilitation Unit	1
Siemens Healthcare A/S	1
Steno Diabetes Center Copenhagen	41
Svendborg Municipality Alcohol Rehabilitation Unit	1
University of Copenhagen	170
University of Oslo	116
University of Southern Denmark	105
VLV Bio, Peviva AB	1

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Department of Gastroenterology and Hepatology, Odense University Hospital	Odense	Denmark	1